Page last updated: 2024-11-04

epibatidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

epibatidine: a powerful, though toxic, pain killer produced by the poison arrow frog, Epipedobates tricolor; structure given in first source; more potent than morphine but acts at nicotine rather than opiate receptors [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID105084
MeSH IDM0220392
PubMed CID1204
CHEMBL ID6623
CHEBI ID91678
SCHEMBL ID316978
MeSH IDM0220392
PubMed CID854023
CHEMBL ID298826
SCHEMBL ID2500147
MeSH IDM0220392

Synonyms (94)

Synonym
PDSP2_000458
epibatidine
(-)-epibatidine
epibatidine, (+/-)
2-(6-chloro-pyridin-3-yl)-7-azonia-bicyclo[2.2.1]heptane
()-2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane(epibatidine)
2-(6-chloropyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
exo-2-(6-chloropyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
2-(6-chloro-pyridin-3-yl)-5-methyl-7-aza-bicyclo[2.2.1]heptane
(2r,4s)-2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
(+)-2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
(-)-2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
(r)-2-(6-chloro-pyridin-3-yl)-7-methyl-7-aza-bicyclo[2.2.1]heptane
bdbm50049757
(2r,4s)-2-(6-chloropyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane (epibatidine)
epibatidine-(+)
2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
epibatidine-(-)
BRD-A39268308-001-02-0
BIO2_000462
BIO2_000942
IDI1_002217
BSPBIO_001263
NCGC00024730-03
NCGC00024730-04
KBIOSS_000603
KBIO3_001065
KBIO2_003171
KBIO2_000603
KBIOGR_000603
KBIO3_001066
KBIO2_005739
(+/-)-epibatidine
NCGC00024730-02
NCGC00024730-05
HMS1990O05
(1r,2r,4s)-epibatidine
CHEMBL6623 ,
HMS1792O05
HMS1362O05
(2r)-2-(6-chloropyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane hydrochloride
(r)-2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
rac-(2r)-2-(6-chloropyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane(+/-) epibatidine
A807623
FT-0643316
[125i]epibatidine
[3h]epibatidine
2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane
gtpl3976
gtpl3977
CCG-208204
SCHEMBL316978
AKOS023808322
208/210 epibatidine
(+/-)-exo-2-(6-chloro-3-pyridinyl)-7-azabicyclo[2.2.1.]heptane
HMS3403O05
SR-01000597620-1
SR-01000597620-3
sr-01000597620
CHEBI:91678
J-007356
()-epibatidine
epibatidine (+/-)
3-(6-chloro-3-pyridinyl)-7-azabicyclo[2.2.1]heptane
Q27163500
Q27077200
cmi 545
7-azabicyclo[2.2.1]heptane, 2-(6-chloro-3-pyridinyl)-, (1r,2r,4s)-rel-
DTXSID30861409
7-azabicyclo(2.2.1)heptane, 2-(6-chloro-3-pyridinyl)-, exo-
7-azabicyclo(2.2.1)heptane, 2-(6-chloro-3-pyridinyl)-, (1r,2r,4s)-
cmi-488
cmi-477
cmi-545
140111-52-0
(2r)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane
EPJ ,
(1r,2r,4s)-2-(6-chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]heptane
bdbm50143314
DB07720
CHEMBL298826 ,
m6k314f1xx ,
unii-m6k314f1xx
SCHEMBL2500147
(1r,2r,4s)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane
7-azabicyclo(2.2.1)heptane, 2-(6-chloro-3-pyridinyl)-, (1r-exo)-
alkaloid 208/210 from dendrobates
epibatidine [mi]
(1r-exo)-2-(6-chloro-3-pyridinyl)-7-azabicyclo(2.2.1)heptane
DTXSID00894067
7-azabicyclo[2.2.1]heptane, 2-(6-chloro-3-pyridinyl)-, (1r,2r,4s)-

Research Excerpts

Overview

Epibatidine is a potent but nonselective nAChR agonist.

ExcerptReferenceRelevance
"Epibatidine is a potent but nonselective nAChR agonist. "( Epibatidine structure-activity relationships.
Carroll, FI, 2004
)
3.21

Toxicity

ExcerptReferenceRelevance
"The present study directly compared the antinociceptive and toxic effects of the neuronal nicotinic receptor agonist ABT-594 ((R)-5-(2-azetidinylmethoxy)-2-chloropyridine) with (-)-nicotine and (+)-epibatidine."( Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
Boyce, S; Hill, RG; Rupniak, NMJ; Russell, MGN; Shepheard, SL; Webb, JK, 2000
)
0.31
" This study examines the hypothesis for the first time that the neonicotinoid insecticides and their imine metabolites and analogs display analgesic (antinociceptive) activity or adverse toxic effects associated with their action on binding to the alpha 4 beta 2 nicotinic acetylcholine receptor (AChR) subtype."( Analgesic and toxic effects of neonicotinoid insecticides in mice.
Casida, JE; Cowan, A; Tomizawa, M, 2001
)
0.31

Compound-Compound Interactions

ExcerptReferenceRelevance
" The nicotinic agonists were given acutely and repeatedly either alone or in combination with a dopamine uptake inhibitor, nomifensine."( Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
Ahtee, L; Janhunen, S; Tuominen, RK, 2005
)
0.33

Bioavailability

ExcerptReferenceRelevance
" Furthermore, the compounds are tertiary amines, implying some advantages in terms of bioavailability pertinent to future in vivo pharmacological studies."( Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
Bräuner-Osborne, H; Falch, E; Frølund, B; Jensen, AA; Krogsgaard-Larsen, P; Mikkelsen, I, 2003
)
0.32

Dosage Studied

The dose-response curve of epibatidine to increase the dopamine output in the caudate-putamen was bell-shaped and clearly differed from that in the accumbens. As anticipated, likely alpha4beta2-nAChR [125I] binding sites increased with treatment (estimated dosage for one-half maximal increase was 0.5 mg/kg)

ExcerptRelevanceReference
" However, a significant shift in (-)-epibatidine's dose-response curve was obtained in animals that received (-)-epibatidine."( Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice.
Damaj, MI; Martin, BR, 1996
)
0.29
" Dose-response curves for agonist-induced ileum contraction indicate that RJR-2429 is equipotent with nicotine, having an EC30 of approximately 2 microM."( The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors.
Bencherif, M; Bhatti, BS; Caldwell, WS; Crooks, P; Fowler, K; Lippiello, PM; Lovette, ME; Reeves, L; Schmitt, JD, 1998
)
0.3
" F3 (30 nM) rapidly and reversibly blocked inward currents generated by pulse applications of nicotine, shifting the dose-response curve to the right in a parallel fashion without changing the maximum response."( Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Clementi, F; Di Angelantonio, S; Gotti, C; Moretti, M; Nistri, A, 2000
)
0.31
" Moreover, dose-related inhibition of brain ChE was similar between age groups, and similar reductions in both QNB and epibatidine binding were noted between the age groups after repeated dosing, even though by the end of the dosing period young animals (juveniles) were still about 3 times more sensitive than adults, based on acute lethality."( Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats.
Olivier, K; Pope, CN; Won, YK; Zheng, Q, 2000
)
0.31
" This dosage of nicotine administered during pregnancy to same rats was shown to result in increased vertical activity in the male offspring [Tizabi Y, Russell LT, Nespor SM, Perry DC, Grunberg NE."( Prenatal nicotine exposure is associated with an increase in [125I]epibatidine binding in discrete cortical regions in rats.
Perry, DC; Tizabi, Y, 2000
)
0.31
" To test this hypothesis, we injected nicotine intraperitoneally in alpha7 mutant mice and found that the dose-response curve for nicotine-induced seizures was similar in the alpha7 +/+, alpha7 +/- and alpha7 -/- mice."( Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures.
Bassetto, L; Broide, R; De Biasi, M; Franceschini, D; Gotti, C; Paylor, R; Salas, R, 2002
)
0.31
" In addition, nicotine in low dosage (10 microM) rescued the decreased rates of cell viability and inhibited the production of lipid peroxidation resulted from H(2)O(2) and Abeta in the cultured cells."( Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells.
Guan, ZZ; Nordberg, A; Yu, WF, 2003
)
0.32
" Similarly to what has been reported concerning nicotine, the dose-response curve of epibatidine to increase the dopamine output in the caudate-putamen was bell-shaped and clearly differed from that in the accumbens."( Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
Ahtee, L; Janhunen, S, 2004
)
0.32
" The dose-response relations for Delta F agreed well with those for epibatidine-induced currents, but were shifted approximately 100-fold to the left of those for ACh-induced currents."( A fluorophore attached to nicotinic acetylcholine receptor beta M2 detects productive binding of agonist to the alpha delta site.
Auyeung, VC; Bezanilla, F; Chanda, B; Dahan, DS; Dibas, MI; Dougherty, DA; Lester, HA; Petersson, EJ, 2004
)
0.32
" An intermittent nicotine dosing regimen designed to resemble nicotine intake in a smoker was administered from GD1-20."( Vaccination against nicotine does not prevent nicotine-induced changes in fetal nicotinic receptor binding and c-fos mRNA expression in rats.
Chen, Y; Dufek, MB; Keyler, DE; Le, C; LeSage, MG; Leslie, FM; Pentel, PR,
)
0.13
" Although Dscam is not the sole gene in the DSCR contributing to enhanced refinement in trisomy, Dscam dosage clearly regulates cell spacing and dendritic fasciculation in a specific class of retinal ganglion cells."( The Down syndrome critical region regulates retinogeniculate refinement.
Barres, BA; Blank, M; Burgess, RW; Feller, MB; Fuerst, PG; Garner, CC; Huberman, AD; Kirkby, L; Nouri, N; Stevens, B; Warrier, D, 2011
)
0.37
" In the present work we studied the in vivo effect of a classic chronic dosing schedule of MDMA in rats, alone or combined with a chronic schedule of NIC, on the density of nAChR and on serotonin reuptake transporters."( 3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors.
Camarasa, J; Escubedo, E; Garcia-Ratés, S; Pubill, D, 2013
)
0.39
" This study examined dose-response relationships for murine α6β2*-nicotinic acetylcholine receptor (nAChR) down-regulation by chronic nicotine treatment."( α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.
Grady, SR; Marks, MJ; McIntosh, JM; Paley, MA; Salminen, O; Wageman, CR; Whiteaker, P, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
alkaloidAny of the naturally occurring, basic nitrogen compounds (mostly heterocyclic) occurring mostly in the plant kingdom, but also found in bacteria, fungi, and animals. By extension, certain neutral compounds biogenetically related to basic alkaloids are also classed as alkaloids. Amino acids, peptides, proteins, nucleotides, nucleic acids, amino sugars and antibiotics are not normally regarded as alkaloids. Compounds in which the nitrogen is exocyclic (dopamine, mescaline, serotonin, etc.) are usually classed as amines rather than alkaloids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (38)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency31.62280.004023.8416100.0000AID485290
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency40.07490.011212.4002100.0000AID1030
regulator of G-protein signaling 4Homo sapiens (human)Potency29.93490.531815.435837.6858AID504845
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency17.78280.035520.977089.1251AID504332
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency35.48130.001815.663839.8107AID894
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuronal acetylcholine receptor subunit alpha-4Mus musculus (house mouse)IC50 (µMol)0.00000.00000.57992.6000AID1101291
Acetylcholine receptor subunit alphaHomo sapiens (human)IC50 (µMol)0.16000.00794.71367.9000AID1101295
Acetylcholine receptor subunit alphaTetronarce californica (Pacific electric ray)Ki0.00270.00279.359634.0000AID219640
Acetylcholine receptor subunit betaTetronarce californica (Pacific electric ray)Ki0.00270.002711.753834.0000AID219640
Acetylcholine receptor subunit gammaTetronarce californica (Pacific electric ray)Ki0.00270.002711.753834.0000AID219640
Acetylcholine receptor subunit deltaTetronarce californica (Pacific electric ray)Ki0.00140.000110.074734.0000AID145845; AID219640
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)Ki0.00030.00000.352210.0000AID1410540; AID145682; AID145685; AID146001; AID146005; AID146006; AID146007; AID146151; AID146159; AID146161; AID146162; AID146163; AID239383; AID254463; AID254464; AID264236; AID264237; AID341261; AID341262; AID427650; AID427651; AID536862
Neuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)Ki0.00000.00000.31570.9700AID1092036
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Ki0.00030.00000.12345.5000AID1359522; AID1410540; AID145682; AID145685; AID145821; AID146455; AID146458; AID146462; AID146484; AID146486; AID146610; AID146617; AID146620; AID146769; AID146771; AID146772; AID146773; AID239384; AID254465; AID254466; AID264238; AID264239; AID264240; AID291933; AID3056; AID341258; AID341263; AID361547; AID427652; AID427654; AID488647; AID536863; AID640179
Neuronal acetylcholine receptor subunit alpha-2Rattus norvegicus (Norway rat)Ki0.00010.00000.04230.4500AID1410540; AID145682; AID145685; AID145859; AID145981; AID145982; AID145983; AID145987; AID145988; AID145989; AID254461; AID254462; AID264234; AID264235; AID341259; AID341260; AID427648; AID427649
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Ki0.00020.00000.10825.5000AID1359522; AID1410540; AID145682; AID145685; AID145821; AID145859; AID145981; AID145982; AID145983; AID146001; AID146005; AID146006; AID146007; AID146455; AID146458; AID146462; AID146484; AID146486; AID146610; AID146617; AID146620; AID239384; AID254461; AID254463; AID254465; AID264234; AID264236; AID264238; AID264240; AID291933; AID3056; AID341258; AID341261; AID361547; AID427650; AID427652; AID488647; AID536863; AID640179
Neuronal acetylcholine receptor subunit beta-3Rattus norvegicus (Norway rat)Ki0.00010.00000.05250.4500AID1410540; AID145682; AID145685
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)Ki0.00030.00000.296310.0000AID1410540; AID145682; AID145685; AID145987; AID145988; AID145989; AID146151; AID146159; AID146161; AID146162; AID146163; AID146769; AID146771; AID146772; AID146773; AID239383; AID254462; AID254464; AID254466; AID264235; AID264237; AID264239; AID341260; AID341262; AID341263; AID427649; AID427651; AID427654; AID536862
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)IC50 (µMol)0.00110.00110.539010.0000AID310061
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)Ki0.00000.00000.11173.5400AID1410535; AID146171; AID146309; AID146635; AID146637; AID1682122; AID239326; AID276249
Neuronal acetylcholine receptor subunit alpha-5Rattus norvegicus (Norway rat)Ki0.00010.00000.05250.4500AID1410540; AID145682; AID145685
Acetylcholine receptor subunit beta-like 2Drosophila melanogaster (fruit fly)IC50 (µMol)0.43000.00230.85314.0000AID1101298
Acetylcholine receptor subunit beta-like 2Drosophila melanogaster (fruit fly)Ki0.29000.00120.57192.7000AID1092037
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)Ki0.00020.00010.62945.4000AID1359525; AID1410534; AID145990; AID146167; AID146775; AID1682119; AID276250
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)Ki0.00020.00000.65225.4000AID1359525; AID1410534; AID146167; AID1682119; AID239326; AID276250
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)IC50 (µMol)0.03100.00204.15279.9000AID1101293
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)Ki0.01000.00221.742710.0000AID1410536; AID146787; AID147083; AID1682334; AID239634
Neuronal acetylcholine receptor subunit alpha-6Rattus norvegicus (Norway rat)Ki0.00010.00000.05250.4500AID1410540; AID145682; AID145685
Neuronal acetylcholine receptor subunit alpha-9Rattus norvegicus (Norway rat)Ki0.00010.00000.05250.4500AID1410540; AID145682; AID145685
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)IC50 (µMol)0.00110.00110.491110.0000AID310061
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)Ki0.00000.00000.11573.5400AID1410535; AID146171; AID146309; AID146635; AID146637; AID146775; AID1682122; AID276249
Acetylcholine-binding proteinLymnaea stagnalis (great pond snail)Ki0.00030.00011.881128.0000AID1092034
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)Ki0.01330.00000.73078.0000AID1410540; AID145682; AID145685; AID146931; AID146939; AID361547; AID488648
Neuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)Ki0.00010.00010.04460.1030AID145990
Soluble acetylcholine receptorAplysia californica (California sea hare)Ki0.00100.00101.22766.3096AID1092035
Neuronal acetylcholine receptor subunit alpha-10Rattus norvegicus (Norway rat)Ki0.00010.00000.05250.4500AID1410540; AID145682; AID145685
TransporterRattus norvegicus (Norway rat)Ki0.00010.00010.866710.0000AID145845
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Ki0.00240.00000.12345.5000AID146618; AID146620; AID146621; AID1799761; AID225733; AID276254
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Ki0.00010.00000.10825.5000AID146618; AID146620; AID146621; AID225733; AID276254
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)Ki0.00020.00010.62945.4000AID1563867
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)Ki0.00020.00000.65225.4000AID1563867
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)Ki0.07100.00221.742710.0000AID1275130; AID1739243
Acetylcholine-binding proteinLymnaea stagnalis (great pond snail)Ki0.00610.00011.881128.0000AID1799761
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)Ki0.05410.00000.73078.0000AID146941; AID1799761
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Acetylcholine receptor subunit alphaHomo sapiens (human)EC50 (µMol)0.00010.00013.337010.0000AID246397
Acetylcholine receptor subunit alphaTetronarce californica (Pacific electric ray)EC50 (µMol)0.20000.20000.20000.2000AID219638
Acetylcholine receptor subunit betaTetronarce californica (Pacific electric ray)EC50 (µMol)0.20000.20000.20000.2000AID219638
Acetylcholine receptor subunit gammaTetronarce californica (Pacific electric ray)EC50 (µMol)0.20000.20000.20000.2000AID219638
Acetylcholine receptor subunit deltaTetronarce californica (Pacific electric ray)EC50 (µMol)0.20000.10000.16670.2000AID145357; AID219638
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)EC50 (µMol)0.14270.00001.011610.0000AID1410542; AID145657; AID146157; AID146158; AID240159; AID246719; AID536867
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)Kd0.00020.00000.00010.0003AID146000; AID146150
Acetylcholine receptor subunit gammaHomo sapiens (human)EC50 (µMol)0.00010.00010.00550.0110AID246397
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)EC50 (µMol)0.02740.01402.272410.0000AID145657; AID146297; AID146316; AID146321; AID146477
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Kd0.00010.00000.00010.0001AID146452; AID146768; AID238150
Acetylcholine receptor subunit betaHomo sapiens (human)EC50 (µMol)0.00010.00010.00550.0110AID246397
Neuronal acetylcholine receptor subunit alpha-2Rattus norvegicus (Norway rat)EC50 (µMol)0.10000.10002.104010.0000AID145657
Neuronal acetylcholine receptor subunit alpha-2Rattus norvegicus (Norway rat)Kd0.00000.00000.00010.0001AID145858; AID145986
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)EC50 (µMol)0.02740.01402.310410.0000AID145657; AID146297; AID146316; AID146321; AID146477
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Kd0.00000.00000.00000.0001AID145858; AID146000; AID146452; AID238150
Neuronal acetylcholine receptor subunit beta-3Rattus norvegicus (Norway rat)EC50 (µMol)0.10000.04601.761010.0000AID145657
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)EC50 (µMol)0.14270.00001.010110.0000AID1410542; AID145657; AID146157; AID146158; AID240159; AID246719; AID536867
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)Kd0.00020.00010.00010.0003AID145986; AID146150; AID146768
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)EC50 (µMol)0.03560.00001.51729.4000AID1410544; AID146297; AID246575; AID291934; AID302773; AID417951; AID675880
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)Kd0.00000.00000.00000.0000AID238148
Neuronal acetylcholine receptor subunit alpha-5Rattus norvegicus (Norway rat)EC50 (µMol)0.10000.10002.104010.0000AID145657
Adenosine receptor A2aRattus norvegicus (Norway rat)EC50 (µMol)0.00000.00000.11560.7200AID246575
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)EC50 (µMol)0.01720.00703.454010.0000AID145356; AID146165; AID282345; AID302774; AID417953
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)Kd0.00030.00030.00030.0003AID238149
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)EC50 (µMol)0.01580.00702.25879.4000AID145356; AID146165; AID225721; AID282345; AID302774; AID417953
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)Kd0.00020.00000.00020.0003AID238148; AID238149
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)EC50 (µMol)3.50000.12802.80188.9000AID146779
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)Kd0.00370.00110.04040.1580AID238082; AID689290
Neuronal acetylcholine receptor subunit alpha-6Rattus norvegicus (Norway rat)EC50 (µMol)0.10000.04601.761010.0000AID145657
Neuronal acetylcholine receptor subunit alpha-9Rattus norvegicus (Norway rat)EC50 (µMol)0.10000.10002.104010.0000AID145657
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)EC50 (µMol)0.03560.00001.61869.4000AID1410544; AID146297; AID246575; AID291934; AID302773; AID417951; AID675880
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)EC50 (µMol)0.70000.00021.848110.0000AID145657; AID146798
Acetylcholine receptor subunit deltaHomo sapiens (human)EC50 (µMol)0.00010.00010.00550.0110AID246397
Neuronal acetylcholine receptor subunit alpha-10Rattus norvegicus (Norway rat)EC50 (µMol)0.10000.10002.104010.0000AID145657
TransporterRattus norvegicus (Norway rat)Kd0.00000.00000.00000.0000AID145858
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)Kd0.00000.00000.00000.0000AID1275134
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)Kd0.00030.00030.00030.0003AID1275133
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)Kd0.00030.00000.00020.0003AID1275133
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)Kd0.00000.00000.00000.0000AID1275134
Acetylcholine-binding proteinLymnaea stagnalis (great pond snail)Kd0.00140.00010.53163.6308AID1799850
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)Affinity0.00050.00050.11030.2200AID243385
Neuronal acetylcholine receptor subunit alpha-3Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Kapp6.47500.00051.65116.9000AID1682111; AID1682112
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)Affinity0.00000.00000.00010.0001AID243384
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit alpha-2Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)Affinity0.00000.00000.00010.0001AID243384
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit beta-3Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)Affinity0.00050.00050.11030.2200AID243385
Neuronal acetylcholine receptor subunit beta-4Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)Activity0.00500.00500.00500.0050AID146464
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)ED500.01700.01702.00854.0000AID1682121
Neuronal acetylcholine receptor subunit beta-2Homo sapiens (human)INH0.00010.00010.00010.0001AID452525
Neuronal acetylcholine receptor subunit alpha-5Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)Activity0.00500.00500.00500.0050AID146155
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)ED500.01900.01900.01900.0190AID1682118
Neuronal acetylcholine receptor subunit beta-4Homo sapiens (human)INH0.00030.00030.00030.0003AID452526
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)Activity0.00500.00500.00500.0050AID146155
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)ED500.01900.01900.01900.0190AID1682118
Neuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)INH0.00030.00030.00030.0003AID452526
Neuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)ED501.10001.10001.10001.1000AID1682117
Neuronal acetylcholine receptor subunit alpha-6Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit alpha-9Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)Activity0.00500.00500.00500.0050AID146464
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)ED500.01700.01702.00854.0000AID1682121
Neuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)INH0.00010.00010.00010.0001AID452525
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)Activity0.50000.50000.50000.5000AID146792
Neuronal acetylcholine receptor subunit alpha-7Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
Neuronal acetylcholine receptor subunit alpha-10Rattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
TransporterRattus norvegicus (Norway rat)K app0.00000.00000.00310.0062AID145677
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (92)

Processvia Protein(s)Taxonomy
neuromuscular synaptic transmissionAcetylcholine receptor subunit alphaHomo sapiens (human)
neuromuscular junction developmentAcetylcholine receptor subunit alphaHomo sapiens (human)
regulation of membrane potentialAcetylcholine receptor subunit alphaHomo sapiens (human)
skeletal muscle contractionAcetylcholine receptor subunit alphaHomo sapiens (human)
monoatomic cation transportAcetylcholine receptor subunit alphaHomo sapiens (human)
neuronal action potentialAcetylcholine receptor subunit alphaHomo sapiens (human)
monoatomic ion transmembrane transportAcetylcholine receptor subunit alphaHomo sapiens (human)
regulation of membrane potentialAcetylcholine receptor subunit alphaHomo sapiens (human)
muscle cell cellular homeostasisAcetylcholine receptor subunit alphaHomo sapiens (human)
skeletal muscle tissue growthAcetylcholine receptor subunit alphaHomo sapiens (human)
musculoskeletal movementAcetylcholine receptor subunit alphaHomo sapiens (human)
neuromuscular processAcetylcholine receptor subunit alphaHomo sapiens (human)
excitatory postsynaptic potentialAcetylcholine receptor subunit alphaHomo sapiens (human)
neuron cellular homeostasisAcetylcholine receptor subunit alphaHomo sapiens (human)
membrane depolarizationAcetylcholine receptor subunit alphaHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholine receptor subunit alphaHomo sapiens (human)
response to nicotineAcetylcholine receptor subunit alphaHomo sapiens (human)
synaptic transmission, cholinergicAcetylcholine receptor subunit alphaHomo sapiens (human)
muscle contractionAcetylcholine receptor subunit gammaHomo sapiens (human)
signal transductionAcetylcholine receptor subunit gammaHomo sapiens (human)
synaptic transmission, cholinergicAcetylcholine receptor subunit gammaHomo sapiens (human)
monoatomic ion transmembrane transportAcetylcholine receptor subunit gammaHomo sapiens (human)
excitatory postsynaptic potentialAcetylcholine receptor subunit gammaHomo sapiens (human)
membrane depolarizationAcetylcholine receptor subunit gammaHomo sapiens (human)
chemical synaptic transmissionAcetylcholine receptor subunit gammaHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholine receptor subunit gammaHomo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
response to nicotineNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
membrane depolarizationNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
postsynaptic membrane organizationAcetylcholine receptor subunit betaHomo sapiens (human)
monoatomic cation transportAcetylcholine receptor subunit betaHomo sapiens (human)
muscle contractionAcetylcholine receptor subunit betaHomo sapiens (human)
signal transductionAcetylcholine receptor subunit betaHomo sapiens (human)
synaptic transmission, cholinergicAcetylcholine receptor subunit betaHomo sapiens (human)
neuromuscular synaptic transmissionAcetylcholine receptor subunit betaHomo sapiens (human)
monoatomic ion transmembrane transportAcetylcholine receptor subunit betaHomo sapiens (human)
behavioral response to nicotineAcetylcholine receptor subunit betaHomo sapiens (human)
regulation of membrane potentialAcetylcholine receptor subunit betaHomo sapiens (human)
nervous system processAcetylcholine receptor subunit betaHomo sapiens (human)
muscle cell developmentAcetylcholine receptor subunit betaHomo sapiens (human)
excitatory postsynaptic potentialAcetylcholine receptor subunit betaHomo sapiens (human)
membrane depolarizationAcetylcholine receptor subunit betaHomo sapiens (human)
chemical synaptic transmissionAcetylcholine receptor subunit betaHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholine receptor subunit betaHomo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
smooth muscle contractionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
visual perceptionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
sensory perception of soundNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
learningNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
memoryNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
locomotory behaviorNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
associative learningNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
visual learningNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of dopamine secretionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
sensory perception of painNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
vestibulocochlear nerve developmentNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
optic nerve morphogenesisNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
lateral geniculate nucleus developmentNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
central nervous system projection neuron axonogenesisNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
positive regulation of B cell proliferationNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of synaptic transmission, dopaminergicNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
positive regulation of dopamine secretionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
social behaviorNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of dopamine metabolic processNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
B cell activationNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to cocaineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of circadian sleep/wake cycle, REM sleepNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to ethanolNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
negative regulation of action potentialNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of dendrite morphogenesisNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
nervous system processNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of synapse assemblyNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
synaptic transmission involved in micturitionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
smooth muscle contractionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
regulation of smooth muscle contractionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
locomotory behaviorNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
neuronal action potentialNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
regulation of neurotransmitter secretionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
positive regulation of transmission of nerve impulseNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
synaptic transmission involved in micturitionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of smooth muscle contractionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
activation of transmembrane receptor protein tyrosine kinase activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
nervous system developmentNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
locomotory behaviorNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of acetylcholine secretion, neurotransmissionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of dendrite morphogenesisNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
synaptic transmission involved in micturitionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
negative regulation of tumor necrosis factor productionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of protein phosphorylationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
intracellular calcium ion homeostasisNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
learning or memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
short-term memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of cell population proliferationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
negative regulation of tumor necrosis factor productionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of MAPK cascadeNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of angiogenesisNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synapse organizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
sensory processingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of protein metabolic processNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
dendritic spine organizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
modulation of excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
dendrite arborizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of long-term synaptic potentiationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of amyloid-beta formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
negative regulation of amyloid-beta formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of amyloid precursor protein catabolic processNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to amyloid-betaNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of amyloid fibril formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of CoA-transferase activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
action potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
DNA repairNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
response to oxidative stressNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
regulation of dopamine secretionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
sensory perception of painNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
B cell activationNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
nervous system processNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
inhibitory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
skeletal muscle contractionAcetylcholine receptor subunit deltaHomo sapiens (human)
monoatomic cation transportAcetylcholine receptor subunit deltaHomo sapiens (human)
muscle contractionAcetylcholine receptor subunit deltaHomo sapiens (human)
signal transductionAcetylcholine receptor subunit deltaHomo sapiens (human)
synaptic transmission, cholinergicAcetylcholine receptor subunit deltaHomo sapiens (human)
monoatomic ion transmembrane transportAcetylcholine receptor subunit deltaHomo sapiens (human)
skeletal muscle tissue growthAcetylcholine receptor subunit deltaHomo sapiens (human)
musculoskeletal movementAcetylcholine receptor subunit deltaHomo sapiens (human)
neuromuscular processAcetylcholine receptor subunit deltaHomo sapiens (human)
excitatory postsynaptic potentialAcetylcholine receptor subunit deltaHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholine receptor subunit deltaHomo sapiens (human)
chemical synaptic transmissionAcetylcholine receptor subunit deltaHomo sapiens (human)
membrane depolarizationAcetylcholine receptor subunit deltaHomo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
cellular response to nicotineNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
modulation of inhibitory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
smooth muscle contractionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
visual perceptionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
sensory perception of soundNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
learningNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
memoryNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
locomotory behaviorNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
associative learningNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
visual learningNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of dopamine secretionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
sensory perception of painNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
vestibulocochlear nerve developmentNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
optic nerve morphogenesisNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
lateral geniculate nucleus developmentNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
central nervous system projection neuron axonogenesisNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
positive regulation of B cell proliferationNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of synaptic transmission, dopaminergicNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
positive regulation of dopamine secretionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
social behaviorNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of dopamine metabolic processNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
B cell activationNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to cocaineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of circadian sleep/wake cycle, REM sleepNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to ethanolNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
negative regulation of action potentialNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of dendrite morphogenesisNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
nervous system processNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
regulation of synapse assemblyNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
synaptic transmission involved in micturitionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
smooth muscle contractionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
regulation of smooth muscle contractionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
locomotory behaviorNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
neuronal action potentialNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
regulation of neurotransmitter secretionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
positive regulation of transmission of nerve impulseNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
synaptic transmission involved in micturitionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of smooth muscle contractionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
activation of transmembrane receptor protein tyrosine kinase activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
nervous system developmentNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
locomotory behaviorNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of acetylcholine secretion, neurotransmissionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
regulation of dendrite morphogenesisNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
synaptic transmission involved in micturitionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
negative regulation of tumor necrosis factor productionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of protein phosphorylationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
intracellular calcium ion homeostasisNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
learning or memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
short-term memoryNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of cell population proliferationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
negative regulation of tumor necrosis factor productionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of MAPK cascadeNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of angiogenesisNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synapse organizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
sensory processingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of protein metabolic processNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
dendritic spine organizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
modulation of excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
dendrite arborizationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of long-term synaptic potentiationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of amyloid-beta formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
negative regulation of amyloid-beta formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of amyloid precursor protein catabolic processNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to amyloid-betaNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
response to acetylcholineNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of amyloid fibril formationNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of CoA-transferase activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
positive regulation of excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
action potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
response to hypoxiaNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
DNA repairNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
monoatomic ion transportNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
calcium ion transportNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
response to oxidative stressNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
signal transductionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
chemical synaptic transmissionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
synaptic transmission, cholinergicNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
regulation of dopamine secretionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
sensory perception of painNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
monoatomic ion transmembrane transportNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
response to nicotineNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
behavioral response to nicotineNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
B cell activationNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
regulation of membrane potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
nervous system processNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
cognitionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
membrane depolarizationNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
excitatory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
inhibitory postsynaptic potentialNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine receptor signaling pathwayNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (17)

Processvia Protein(s)Taxonomy
acetylcholine receptor activityAcetylcholine receptor subunit alphaHomo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit alphaHomo sapiens (human)
acetylcholine bindingAcetylcholine receptor subunit alphaHomo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit alphaHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialAcetylcholine receptor subunit alphaHomo sapiens (human)
protein bindingAcetylcholine receptor subunit gammaHomo sapiens (human)
channel activityAcetylcholine receptor subunit gammaHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialAcetylcholine receptor subunit gammaHomo sapiens (human)
acetylcholine receptor activityAcetylcholine receptor subunit gammaHomo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit gammaHomo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
acetylcholine receptor activityAcetylcholine receptor subunit betaHomo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit betaHomo sapiens (human)
protein bindingAcetylcholine receptor subunit betaHomo sapiens (human)
channel activityAcetylcholine receptor subunit betaHomo sapiens (human)
ligand-gated monoatomic ion channel activityAcetylcholine receptor subunit betaHomo sapiens (human)
acetylcholine bindingAcetylcholine receptor subunit betaHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialAcetylcholine receptor subunit betaHomo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit betaHomo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
protein-containing complex bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
quaternary ammonium group bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
heterocyclic compound bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
protein bindingNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
amyloid-beta bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
toxic substance bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
chloride channel regulator activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein homodimerization activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit deltaHomo sapiens (human)
acetylcholine bindingAcetylcholine receptor subunit deltaHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialAcetylcholine receptor subunit deltaHomo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityAcetylcholine receptor subunit deltaHomo sapiens (human)
acetylcholine receptor activityAcetylcholine receptor subunit deltaHomo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
quaternary ammonium group bindingNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
heterocyclic compound bindingNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
protein-containing complex bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
quaternary ammonium group bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
heterocyclic compound bindingNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
amyloid-beta bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
calcium channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
toxic substance bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
chloride channel regulator activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein homodimerization activityNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
protein bindingNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
ligand-gated monoatomic ion channel activityNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine receptor activityNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine-gated monoatomic cation-selective channel activityNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine bindingNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (26)

Processvia Protein(s)Taxonomy
neuromuscular junctionAcetylcholine receptor subunit alphaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit alphaHomo sapiens (human)
cell surfaceAcetylcholine receptor subunit alphaHomo sapiens (human)
neuromuscular junctionAcetylcholine receptor subunit alphaHomo sapiens (human)
postsynaptic membraneAcetylcholine receptor subunit alphaHomo sapiens (human)
postsynaptic specialization membraneAcetylcholine receptor subunit alphaHomo sapiens (human)
acetylcholine-gated channel complexAcetylcholine receptor subunit alphaHomo sapiens (human)
synapseAcetylcholine receptor subunit alphaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit alphaHomo sapiens (human)
neuron projectionAcetylcholine receptor subunit alphaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit gammaHomo sapiens (human)
postsynaptic membraneAcetylcholine receptor subunit gammaHomo sapiens (human)
acetylcholine-gated channel complexAcetylcholine receptor subunit gammaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit gammaHomo sapiens (human)
synapseAcetylcholine receptor subunit gammaHomo sapiens (human)
neuron projectionAcetylcholine receptor subunit gammaHomo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
neuron projectionNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
synapseNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
plasma membraneNeuronal acetylcholine receptor subunit alpha-4Gallus gallus (chicken)
neuromuscular junctionAcetylcholine receptor subunit betaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit betaHomo sapiens (human)
synapseAcetylcholine receptor subunit betaHomo sapiens (human)
postsynaptic specialization membraneAcetylcholine receptor subunit betaHomo sapiens (human)
acetylcholine-gated channel complexAcetylcholine receptor subunit betaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit betaHomo sapiens (human)
synapseAcetylcholine receptor subunit betaHomo sapiens (human)
neuron projectionAcetylcholine receptor subunit betaHomo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
external side of plasma membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
presynaptic membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
cholinergic synapseNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
postsynaptic specialization membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
plasma membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
specific granule membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
tertiary granule membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
cholinergic synapseNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
endoplasmic reticulumNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
Golgi apparatusNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
postsynaptic densityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
nuclear speckNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
dendriteNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
neuronal cell bodyNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
postsynapseNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-9Rattus norvegicus (Norway rat)
plasma membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
external side of plasma membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
dendriteNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
neuronal cell bodyNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
neuromuscular junctionAcetylcholine receptor subunit deltaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit deltaHomo sapiens (human)
acetylcholine-gated channel complexAcetylcholine receptor subunit deltaHomo sapiens (human)
postsynaptic membraneAcetylcholine receptor subunit deltaHomo sapiens (human)
postsynaptic specialization membraneAcetylcholine receptor subunit deltaHomo sapiens (human)
plasma membraneAcetylcholine receptor subunit deltaHomo sapiens (human)
neuron projectionAcetylcholine receptor subunit deltaHomo sapiens (human)
synapseAcetylcholine receptor subunit deltaHomo sapiens (human)
nucleoplasmNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
intercellular bridgeNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
neuron projection cytoplasmNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-2Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-10Rattus norvegicus (Norway rat)
plasma membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
external side of plasma membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
presynaptic membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
cholinergic synapseNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
postsynaptic specialization membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit beta-2Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
specific granule membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
tertiary granule membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
cholinergic synapseNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit beta-4Homo sapiens (human)
endoplasmic reticulumNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
Golgi apparatusNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
postsynaptic densityNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
nuclear speckNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
dendriteNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
neuronal cell bodyNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-3Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membrane raftNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
postsynapseNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-7Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
external side of plasma membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
dendriteNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
neuronal cell bodyNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
postsynaptic membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
acetylcholine-gated channel complexNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
synapseNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
neuron projectionNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
plasma membraneNeuronal acetylcholine receptor subunit alpha-4Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (429)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID239324Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha2-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID229712Functional / binding potency ratio for nAChR subtype alpha4-beta2 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID238082Dissociation constant for nicotinic acetylcholine receptor alpha 7 from human neuroblastoma SH-SY5Y cells; n=32005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
AID231911Ratio between the binding affinities towards rat alpha2-beta4 and alpha2-beta2 nACh receptor using [3H]-EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID246575Change in membrane potential in K-177 cells expressing acetylcholine central neuronal receptor alpha4-beta2 subunits 2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID374844Binding affinity to Aplysia californica AchBP A107M, M116L, Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1101292Inhibition of [3H]nicotine binding to alpha3 nicotinic acetylcholine receptor in Homo sapiens (human) SH-SY5Y cells co-expressing beta2beta4alpha5 Nicotinic acetylcholine receptor subunits2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID146309Binding affinity to alpha4 beta-2 receptor subtype from mouse fibroblast M10 cells was measured using [3 H]nicotine2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
5-Azidoepibatidine: an exceptionally potent photoaffinity ligand for neuronal alpha 4 beta 2 and alpha 7 nicotinic acetylcholine receptors.
AID14401Biodistribution in rat thalamus, expressed as percent I.D./g tissue1999Journal of medicinal chemistry, Jun-17, Volume: 42, Issue:12
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
AID264241Selectivity for rat alpha-4-beta-2 nACHR over alpha3beta4 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID1101298Inhibition of [3H]IMI binding to Drosophila melanogaster neuronal acetylcholine receptor2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID145982Binding affinity towards rat alpha2-beta2 neuronal nAChR expressed in Xenopus oocytes using [3H]epibatidine as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID113223Analgesic efficacy is expressed as percentage of that morphine, done on mouse.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID374879Binding affinity to Aplysia californica AchBP V108M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1682121Agonist activity at human alpha4beta2 nAChR expressed in human K177 cell membrane assessed as increase in 86-rubidium efflux incubated for 5 mins by gamma counting method2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1682120Displacement of [125I]alpha-bungarotoxin from Torpedo californica electroplax alpha1beta1deltagamma nACHR incubated for 1 hr by gamma counter method2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID239611Displacement of [3H]epibatidine from Alpha3 Beta4 Nicotinic acetylcholine receptor of rat brain homogenates2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
AID146321Functional potency for Nicotinic acetylcholine receptor alpha4-beta2 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID225721Functional activation of human sympathetic ganglionic type nAChRs in IMR-32 cells containing alpha-3 subtype1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
AID1074611Agonist activity at rat alpha7 nAChR expressed in Xenopus laevis oocytes assessed as stimulation of acetylcholine-induced current at 100 uM by two-electrode voltage clamp electrophysiological analysis relative to acetylcholine2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID1682117Agonist activity at human alpha7 nAChR (unknown origin)2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID238146Dissociation constant against Nicotinic acetylcholine receptor alpha2-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID375124Binding affinity to Aplysia californica AchBP I118M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID341257Displacement of [3H]epibatidine from nAChR in rat cerebral cortex membrane2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID427648Displacement of [3H]epibatidine from rat alpha2beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID146631Functional potency measured as maximum stimulation at rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID113222Analgesic efficacy is expressed as percentage of that epibatidine, done on mouse.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID1682112Displacement of [3H]-NMS from rat cerebral cortex muscarinic M1 receptor incubated for 60 mins by liquid scintillation spectrometry2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1410536Displacement of [3H]epibatidine from alpha7 nAChR (unknown origin) expressed in HEK cell membranes after 4 hrs by liquid scintillation counting method2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID374869Binding affinity to Aplysia californica AchBP M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1682115Displacement of [3H]-(-)-nicotine from rat cerebral cortex nAChR incubated for 60 mins by liquid scintillation spectrometry2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID145989Binding affinity towards rat Nicotinic acetylcholine receptor alpha2-beta4 expressed in Xenopus oocytes using [3H]epibatidine as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID341262Displacement of [3H]epibatidine from rat alpha3beta4 nAChR expressed in HEK293 cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID488647Displacement of (+/-)-[3H]epibatidine from alpha4beta2 nAChR in rat cortical membrane2010Bioorganic & medicinal chemistry, Jun-15, Volume: 18, Issue:12
Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes.
AID374882Binding affinity to Aplysia californica AchBP I118M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146630in vitro binding affinity by inhibiting [3H]cytisine binding in rat brain tissue at Nicotinic acetylcholine receptor alpha4-beta22002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
AID264234Displacement of [3H]epibatidine from rat alpha-2-beta-2 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID242876Maximal response against Nicotinic acetylcholine receptor alpha3-beta42005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
AID374848Binding affinity to Aplysia californica AchBP V108M, M116L mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146163Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in Xenopus oocytes using [3H]epibatidine as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID146484Binding affinity towards Nicotinic acetylcholine receptor alpha4-beta2 using [3H]epibatidine2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
AID1410534Displacement of [3H]epibatidine from alpha3beta4 nAChR (unknown origin) expressed in HEK cell membranes after 4 hrs by liquid scintillation counting method2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID1410542Agonist activity at rat alpha3beta4 nAChR by cell-based rubidium flux assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID1359525Displacement of [3H]epibatidine from human alpha3beta4 nAChR expressed in HEK293 cell membranes2018European journal of medicinal chemistry, May-25, Volume: 152Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: Novel selective ligands with subnanomolar affinity for α
AID146149Binding affinity to Nicotinic acetylcholine receptor alpha3-beta4 using +/-[3H]epibatidine as radioligand in pig adrenal gland2002Journal of medicinal chemistry, Feb-28, Volume: 45, Issue:5
Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.
AID374881Binding affinity to Aplysia californica AchBP S114M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1101291Inhibition of [3H]nicotine binding to alpha4 nicotinic acetylcholine receptor in Mus musculus (mouse) M10 cells co-expressing beta2 nicotinic acetylcholine receptor subunits2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID242878Maximal response against Nicotinic acetylcholine receptor alpha4-beta42005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
AID427650Displacement of [3H]epibatidine from rat alpha3beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID374856Binding affinity to Aplysia californica AchBP S114M, M116L, Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID240159Effective concentration against alpha3-beta4 nicotinic acetylcholine receptor (nAChR) expressed in IMR32 cell 2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
AID427655Selectivity ratio of Ki for rat alpha3beta4 nicotinic receptor to Ki for rat alpha4beta2 nicotinic receptor2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID322347Antinociceptive activity in sc dosed mouse assessed as inhibition of nicotin induced hypothermia2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.
AID1682113Displacement of [3H]-Cytisine from rat cerebral cortex nAChR at 10 uM by radioligand binding assay relative to control2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID146775Binding affinity against nicotinic acetylcholine receptor alpha4-beta4 using [3H]epibatidine as radioligand expressed in HEK293 cells or tsA cells2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Synthesis and nicotinic receptor activity of a hydroxylated tropane.
AID146162Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID239302Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha4-beta42005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID1682114Displacement of [3H]-Pirenzepine from rat cerebral cortex Muscarinic M1 receptor at 10 uM by radioligand binding assay relative to control2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID374878Binding affinity to Aplysia californica AchBP V108M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID145685Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID239325Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha2-beta42005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID1682118Agonist activity at human alpha3beta4 nAChR expressed in mouse/rat hybrid F11 cells assessed as increase in rubidium-86 efflux2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID145343Binding affinity to Drosophila nicotinic receptor was measured using [3H]imidacloprid as radioligand2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
5-Azidoepibatidine: an exceptionally potent photoaffinity ligand for neuronal alpha 4 beta 2 and alpha 7 nicotinic acetylcholine receptors.
AID94460Ability to stimulate Rb+ efflux from human K177 cell preparations containing human alpha4-beta2 receptors1996Journal of medicinal chemistry, Feb-16, Volume: 39, Issue:4
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
AID264236Displacement of [3H]epibatidine from rat alpha-3-beta-2 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID1682124Displacement of [3H]cytisine from rat brain nAChR using radiolabelled compound2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID318725Displacement of [3H]ACE from Aplysia AChBP expressed in HEK293S cells by scintillation proximity assay2007Proceedings of the National Academy of Sciences of the United States of America, May-22, Volume: 104, Issue:21
Mapping the elusive neonicotinoid binding site.
AID239384Inhibition of [3H]epibatidine binding to rat Nicotinic acetylcholine receptor alpha4-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID145663Binding affinity towards nicotinic acetylcholine receptor using [125I]alpha-bungarotoxin as radioligand in rat forebrain homogenates2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Rigidified acetylcholine mimics: conformational requirements for binding to neuronal nicotinic receptors.
AID145345Potency to displace [3H]IMI binding to Nicotinic acetylcholine receptor from Drosophila head membranes2002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
Structural features of azidopyridinyl neonicotinoid probes conferring high affinity and selectivity for mammalian alpha4beta2 and Drosophila nicotinic receptors.
AID1101295Inhibition of [3H]alpha-BGT binding to alpha1 nicotinic acetylcholine receptor in Homo sapiens (human) TE671 cells co-expressing gammaalpha1deltabeta1 nicotinic acetylcholine receptor subunits2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID374876Binding affinity to Aplysia californica AchBP A107M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID246719Effective concentration in KXalpha-3-beta-4R2 cells expressing rat nicotinic acetylcholine receptor alpha3-beta4 subunits2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID145986Tested for binding affinity against Nicotinic acetylcholine receptor alpha2-beta42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID145988Binding affinity towards Nicotinic acetylcholine receptor alpha2-beta4 using [3H]epibatidine2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
AID146001Tested for binding affinity against Nicotinic acetylcholine receptor alpha3-beta22003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID242872Maximal response against Nicotinic acetylcholine receptor alpha 72005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
AID1410535Displacement of [3H]epibatidine from alpha4beta2 nAChR (unknown origin) expressed in HEK cell membranes after 4 hrs by liquid scintillation counting method2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID1410537Selectivity ratio of Ki for displacement of [3H]epibatidine from alpha3beta4 nAChR (unknown origin) expressed in HEK cell membranes to Ki for displacement of [3H]epibatidine from alpha4beta2 nAChR (unknown origin) expressed in HEK cell membranes2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID146314Affinity at alpha4-beta2 nACh receptors in rat brain (minus cerebellum) homogenates.2003Bioorganic & medicinal chemistry letters, Feb-24, Volume: 13, Issue:4
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors.
AID146297Compound was evaluated for functional potencies and efficacies at human Nicotinic acetylcholine receptor alpha4-beta21997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID94458Cholinergic interactions was measured with FLIPR device on K177l cells and given as Intrinsic activity1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID1682128Displacement of [3H] dihydromorphine from guinea pig brain opioid receptor2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID375119Binding affinity to Aplysia californica AchBP V108M mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID397990Displacement of [3H]A585539 from alpha7 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
AID146779Compound was evaluated for functional potencies and efficacies at human Nicotinic acetylcholine receptor alpha71997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID1682130Antinociceptive activity in naloxone treated mouse assessed as induction of Straub-tail response2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1410538Potency index, ratio of epibatidine Ki to racemic phantasmidine Ki for displacement of [3H]epibatidine from alpha3beta4 nAChR (unknown origin) expressed in HEK cell membranes2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID146167Binding affinity against nicotinic acetylcholine receptor alpha3-beta4 using [3H]epibatidine as radioligand expressed in HEK293 cells or tsA cells2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Synthesis and nicotinic receptor activity of a hydroxylated tropane.
AID1682111Displacement of [3H]-oxo-M from rat cerebral cortex muscarinic M1 receptor incubated for 40 mins by liquid scintillation spectrometry2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID246840Effective dose to induce hypothermia in mouse was determined2005Journal of medicinal chemistry, Feb-24, Volume: 48, Issue:4
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
AID146316Compound was evaluated for functional potencies and efficacies at rat Nicotinic acetylcholine receptor alpha4-beta21997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID374870Binding affinity to Aplysia californica AchBP Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID375121Binding affinity to Aplysia californica AchBP V108M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146770Functional potency measured as stimulation at rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in Xenopus oocytes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1682127Antinociceptive activity against mecamylamine-treated mouse2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID374858Binding affinity to Aplysia californica AchBP I118M mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146617Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID374880Binding affinity to Aplysia californica AchBP S114M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID375117Binding affinity to Aplysia californica AchBP A107M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146486Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID226266Compound was evaluated for the functional selectivity for alpha4-beta2 (rat brain)/ vs alpha-7 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID374860Binding affinity to Aplysia californica AchBP I118M, M116L mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID145858Tested for binding affinity against Nicotinic acetylcholine receptor alpha2-beta22003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID276250Displacement of [3H]epibatidine from human recombinant alpha-3-beta-4 nAChR in HEK293 cells by SPA assay2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Epibatidine isomers and analogues: structure-activity relationships.
AID147090Binding affinity towards nicotinic acetylcholine receptor alpha7 - 5-hydroxytryptamine 3 receptor was determined in transfected HEK cells (alpha7) using [125I]-alpha-BgTx as radioligand2003Bioorganic & medicinal chemistry letters, Mar-24, Volume: 13, Issue:6
Syntheses and biological properties of cysteine-reactive epibatidine derivatives.
AID208871Cholinergic interactions was measured with FLIPR device on TE671 cells and given as Effective dose1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID253369Lethal dose against rodents; Range = 7-67 nmol/kg2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
AID374874Binding affinity to Aplysia californica AchBP A107M mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146792Agonistic activity against rat nicotinic acetylcholine receptor alpha-7 expressed in Xenopus oocytes2001Journal of medicinal chemistry, Jan-04, Volume: 44, Issue:1
exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.
AID264240Displacement of [3H]epibatidine from rat forebrain alpha4beta2 nACHR2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID242891Maximal response against Nicotinic acetylcholine receptor alpha2-beta4 expressed in HEK293 cells2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
AID91541Cholinergic interactions was measured with FLIPR device on cells of IMR-32 human neuroblastoma clonal line and given as Intrinsic activity1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID231914Ratio between the binding affinities towards rat alpha3-beta4 and forebrain nACh receptor using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID417954Agonist activity at human recombinant alpha3beta4 nAChR expressed in human IMR32 cells assessed as calcium dynamics by FLIPR assay relative to nicotine2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
AID229789Ratio of Ki (binding affinity) relative to activation potency2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
AID302773Agonist activity at recombinant human alpha-4-beta-2 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
AID375125Binding affinity to Aplysia californica AchBP I118M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID465077Agonist activity at human alpha3beta4 nAChR in human IMR32 cells assessed as membrane depolarization after 1 hr by HPLC based fluorescence assay2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.
AID225722Intrinsic activity against human sympathetic ganglionic type nAChRs in IMR-32 cells containing alpha-3 subtype1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
AID1092034Binding affinity to freshwater snail Lymnaea stagnalis AChBP assessed as [3H]EPI binding by radioligand binding assay2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Unique neonicotinoid binding conformations conferring selective receptor interactions.
AID375120Binding affinity to Aplysia californica AchBP V108M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID239326Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha3-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID1074609Antagonist activity at rat alpha3beta4 nAChR expressed in Xenopus laevis oocytes assessed as inhibition of acetylcholine-induced current at 100 uM by two-electrode voltage clamp electrophysiological analysis relative to acetylcholine2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID225720Binding affinity towards rat alpha2-beta4 nACh receptor expressed in HEK293 cells using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID417951Agonist activity at human recombinant alpha4beta2 nAChR expressed in human IMR32 cells assessed as calcium dynamics by FLIPR assay2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
AID231912Ratio between the binding affinities towards rat alpha3-beta4 and alpha3-beta2 nACh receptor using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID1682122Displacement of [3H]cytisine from human alpha4beta2 nAChR expressed in human K177 cell membrane incubated for 75 mins by liquid scintillation spectroscopy2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID374884Binding affinity to Aplysia californica AchBP M116Y mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146635Binding affinity at heteropentameric Nicotinic acetylcholine receptor alpha4-beta2 subtype using [3H]bungarotoxin as radioligand1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Molecular recognition in nicotinic acetylcholine receptors: the importance of pi-cation interactions.
AID146935Binding affinity to subtype Nicotinic acetylcholine receptor alpha-7 using [125I]-alpha-BTX as radioligand in rat brain2002Journal of medicinal chemistry, Feb-28, Volume: 45, Issue:5
Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.
AID751661Displacement of [I125]Epibatidine from nAChR in human IMR32 cells after 60 mins2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
AID141666In vitro displacement of [3H]oxotremorine-M from muscarinic acetylcholine receptor in rat brain cortex1999Journal of medicinal chemistry, Dec-02, Volume: 42, Issue:24
Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.
AID427652Displacement of [3H]epibatidine from rat alpha4beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID145668In vitro displacement of [3H]methylcarbamylcholine from nicotinic acetylcholine receptor in rat brain cortex1999Journal of medicinal chemistry, Dec-02, Volume: 42, Issue:24
Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.
AID94462Ability to stimulate Rb+ efflux from human IMR-32 cell preparations containing human alpha3-betaX receptors1996Journal of medicinal chemistry, Feb-16, Volume: 39, Issue:4
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
AID219640Binding potency for nAChR subtype Alpha-1-beta-1-delta gamma(torpedo)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID675880Agonist activity at alpha4beta 2 nAChR2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Synthesis and nicotinic receptor activity of chemical space analogues of N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) and 1,4-diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester (SSR180711).
AID14400Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue1999Journal of medicinal chemistry, Jun-17, Volume: 42, Issue:12
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
AID231915Ratio between the binding affinities towards rat alpha4-beta4 and alpha4-beta2 nACh receptor using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID427651Displacement of [3H]epibatidine from rat alpha3beta4 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID94457Cholinergic interactions was measured with FLIPR device on K177l cells and given as EC50.1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID146459Cholinergic interactions was measured as displaced [3H]cystine from Nicotinic acetylcholine receptor alpha4-beta2 in rat brain membranes1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID146772Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID374872Binding affinity to Aplysia californica AchBP I106M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID374868Binding affinity to wild type Aplysia californica AchBP expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID371854Binding affinity to wild type Aplysia californica AchBP expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID254466In vitro binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 using 0.5 nM [3H]epibatidine2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID145983Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID1074613Agonist activity at rat alpha4beta2 nAChR expressed in Xenopus laevis oocytes assessed as stimulation of acetylcholine-induced current at 100 uM by two-electrode voltage clamp electrophysiological analysis relative to acetylcholine2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID208878Cholinergic interactions was measured with FLIPR device on TE671 cells and given as Intrinsic activity1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID227722Compound was evaluated for the binding selectivity for alpha4-beta2 (rat brain)/ vs alpha-7 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID375118Binding affinity to Aplysia californica AchBP A107M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID374834Binding affinity to Aplysia californica AchBP M116L,Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID374838Binding affinity to Aplysia californica AchBP I106M, M116L, Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID145657Compound was evaluated for functional potencies and efficacies at rat Nicotinic acetylcholine receptor subtype PC12 (ganglionic)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID145666Binding affinity towards nicotinic acetylcholine receptor using [3H]-cytisine as radioligand in rat forebrain homogenates2003Bioorganic & medicinal chemistry letters, Nov-03, Volume: 13, Issue:21
Rigidified acetylcholine mimics: conformational requirements for binding to neuronal nicotinic receptors.
AID1682110Selectivity ratio of displacement of [3H]-NMS from rat cerebral cortex muscarinic M1 receptor to displacement of [3H]-oxo-M from rat cerebral cortex muscarinic M1 receptor2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID1410544Agonist activity at human alpha4beta2 nAChR by cell-based rubidium flux assay2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID374873Binding affinity to Aplysia californica AchBP I106M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1092035Binding affinity to salt water mollusc Aplysia californica AChBP Y55W mutant assessed as [3H]acetamiprid binding by radioligand binding assay2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Unique neonicotinoid binding conformations conferring selective receptor interactions.
AID1682116Agonist activity at Torpedo alpha1beta1deltagamma nACHR2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID254462In vitro binding affinity towards rat Nicotinic acetylcholine receptor alpha2-beta4 using 0.5 nM [3H]epibatidine2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID238151Dissociation constant against Nicotinic acetylcholine receptor alpha4-beta42005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID465078Agonist activity at human alpha3beta4 nAChR in human SH-SY5Y cells assessed as membrane depolarization after 1 hr by HPLC based fluorescence assay2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.
AID361547Displacement of [3H]nicotine from alpha4beta2 nAChR in rat cortical membrane2008Bioorganic & medicinal chemistry letters, Aug-15, Volume: 18, Issue:16
Epiboxidine and novel-related analogues: a convenient synthetic approach and estimation of their affinity at neuronal nicotinic acetylcholine receptor subtypes.
AID302775Agonist activity at recombinant human alpha-4-beta-2 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay relative to nicotine2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
AID177747Agonist activity against alpha beta Nicotinic acetylcholine receptor (nAChR) in male rat cerebral cortex in antinociceptive assay in tail flick test2002Journal of medicinal chemistry, Oct-10, Volume: 45, Issue:21
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
AID229713Functional / binding potency ratio for nAChR subtype Alpha7 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID239381Inhibition of [125I]-iodo-MLA binding to Nicotinic acetylcholine receptor alpha-7 in rat cerebral cortex 2005Journal of medicinal chemistry, Feb-24, Volume: 48, Issue:4
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
AID264237Displacement of [3H]epibatidine from rat alpha3beta4 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID264238Displacement of [3H]epibatidine from rat alpha-4-beta-2 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID146150Tested for binding affinity against Nicotinic acetylcholine receptor alpha3-beta42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID1682125Selectivity ratio of antinociceptive activity against mecamylamine-treated mouse to antinociceptive activity in mouse2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID264235Displacement of [3H]epibatidine from rat alpha-2-beta-4 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID276253Selectivity for human alpha-4-beta-2 nAChR over human alpha3beta4 nAChR2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Epibatidine isomers and analogues: structure-activity relationships.
AID374850Binding affinity to Aplysia californica AchBP V108M, M116L, Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID35535Inhibition of [3H]epibatidine binding at the alpha beta nicotinic AChR in male rat cerebral cortex2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.
AID374854Binding affinity to Aplysia californica AchBP S114M, M116L mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID239634Binding affinity for nicotinic acetylcholine receptor alpha 7 from human neuroblastoma SH-SY5Y cells; n=32005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
AID318726Displacement of [3H]EPI from Aplysia AChBP expressed in HEK293S cells by scintillation proximity assay2007Proceedings of the National Academy of Sciences of the United States of America, May-22, Volume: 104, Issue:21
Mapping the elusive neonicotinoid binding site.
AID282345Agonist activity at alpha-3-beta-4 nAChR in KXalpha-3-beta-4R2 cells by rubidium efflux assay2004Journal of medicinal chemistry, Dec-30, Volume: 47, Issue:27
Coaxing a pyridine nucleus to give up its aromaticity: synthesis and pharmacological characterization of novel conformationally restricted analogues of nicotine and anabasine.
AID14399Biodistribution in rat cerebellum, expressed as percent I.D./g tissue1999Journal of medicinal chemistry, Jun-17, Volume: 42, Issue:12
Synthesis and nicotinic acetylcholine receptor in vivo binding properties of 2-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors.
AID145990Binding affinity against nicotinic acetylcholine receptor alpha2-beta4 using [3H]epibatidine as radioligand expressed in HEK293 cells or tsA cells2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Synthesis and nicotinic receptor activity of a hydroxylated tropane.
AID145682Binding affinity against Nicotinic Acetylcholine Receptor was determined by measuring the displacement of [3H]cytisine from a preparation of whole rat brain.1996Journal of medicinal chemistry, Feb-16, Volume: 39, Issue:4
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
AID238147Dissociation constant against Nicotinic acetylcholine receptor alpha2-beta42005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID374862Binding affinity to Aplysia californica AchBP I118M, M116L, Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146165Agonistic potency against nicotinic acetylcholine receptor alpha3-beta42004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Synthesis and nicotinic receptor activity of a hydroxylated tropane.
AID246898Effective dose to induce antinociception in mouse determined in hotplate test2005Journal of medicinal chemistry, Feb-24, Volume: 48, Issue:4
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
AID276249Displacement of [3H]epibatidine from human recombinant alpha4beta2 nAChR in HEK293 cells by SPA assay2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Epibatidine isomers and analogues: structure-activity relationships.
AID1074612Agonist activity at rat alpha3beta4 nAChR expressed in Xenopus laevis oocytes assessed as stimulation of acetylcholine-induced current at 100 uM by two-electrode voltage clamp electrophysiological analysis relative to acetylcholine2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID640184Selectivity ratio of Ki for displacement of [3H]epibatidine from nAChR alpha4beta2 receptor on rat cortical membrane homogenate to Ki for displacement of [3H]bungarotoxin from nAChR alpha7 receptor on rat cortical membrane homogenate2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.
AID374885Binding affinity to Aplysia californica AchBP M116Y, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID341260Displacement of [3H]epibatidine from rat alpha2beta4 nAChR expressed in HEK293 cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID145357Compound was evaluated for functional potencies and efficacies at human Nicotinic acetylcholine receptor subtype TE671 (muscle)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID146610Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes using [3H]epibatidine as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID536864Displacement of [3H]epibatidine from alpha7 nAChR in rat brain membranes after 2 hrs2010Journal of medicinal chemistry, Nov-25, Volume: 53, Issue:22
Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
AID640179Displacement of [3H]epibatidine from nAChR alpha4beta2 receptor on rat cortical membrane homogenate by beta-counting2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.
AID146787Binding affinity to alpha-7 receptor subtype from human neuroblastoma SH-SY5Y cells was measured using [125I]-alpha-bungarotoxin as radioligand2003Bioorganic & medicinal chemistry letters, Feb-10, Volume: 13, Issue:3
5-Azidoepibatidine: an exceptionally potent photoaffinity ligand for neuronal alpha 4 beta 2 and alpha 7 nicotinic acetylcholine receptors.
AID254465In vitro binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 using 0.5 nM [3H]epibatidine2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID751726Displacement of [I125]Epibatidine from nAChR in human IMR32 cells at 10 uM after 60 mins relative to control2013Bioorganic & medicinal chemistry letters, Mar-15, Volume: 23, Issue:6
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
AID536862Displacement of [3H]epibatidine from rat alpha3beta4 nAChR expressed in HEK292 cells after 3 hrs2010Journal of medicinal chemistry, Nov-25, Volume: 53, Issue:22
Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
AID229710Functional / binding potency ratio for nAChR subtype Alpha1-beta1 delta-gamma-torpedo)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID374875Binding affinity to Aplysia californica AchBP A107M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID239383Inhibition of [3H]epibatidine binding to rat Nicotinic acetylcholine receptor alpha3-beta42005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID251197Percentage efficacy in K-177 cells expressing acetylcholine central neuronal receptor type alpha-4 beta2 subunits as change in membrane potential2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID375126Binding affinity to Aplysia californica AchBP M116Y mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146157Activation potency at Nicotinic acetylcholine receptor alpha3beta4, expressed as concentration required to achieve a half maximal activation2002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
AID1359522Displacement of [3H]epibatidine from alpha4beta2 nAChR in rat cortex membranes2018European journal of medicinal chemistry, May-25, Volume: 152Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: Novel selective ligands with subnanomolar affinity for α
AID302774Agonist activity at recombinant human alpha-3-beta-4 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
AID375115Binding affinity to Aplysia californica AchBP I106M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID145850Selectivity ratio of Ki of Nicotinic acetylcholine receptor of Drosophila to Nicotinic acetylcholine receptor alpha4-beta22002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
Structural features of azidopyridinyl neonicotinoid probes conferring high affinity and selectivity for mammalian alpha4beta2 and Drosophila nicotinic receptors.
AID177745Agonist activity against alpha beta Nicotinic acetylcholine receptor (nAChR) in male rat cerebral cortex in antinociceptive assay in hot plate test2002Journal of medicinal chemistry, Oct-10, Volume: 45, Issue:21
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
AID146771Binding affinity towards Nicotinic acetylcholine receptor alpha4-beta4 using [3H]epibatidine2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
AID296790Displacement of [3H]epibatidine from nAChR of rat cortical membrane2007Journal of medicinal chemistry, Aug-09, Volume: 50, Issue:16
Derivatives of (-)-7-methyl-2-(5-(pyridinyl)pyridin-3-yl)-7-azabicyclo[2.2.1]heptane are potential ligands for positron emission tomography imaging of extrathalamic nicotinic acetylcholine receptors.
AID375122Binding affinity to Aplysia californica AchBP S114M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1682109Toxicity in iv dosed rat2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID146171Potency to displace [3H]nicotine binding to Nicotinic acetylcholine receptor alpha4-beta2 immuno-isolated from M10 cells2002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
Structural features of azidopyridinyl neonicotinoid probes conferring high affinity and selectivity for mammalian alpha4beta2 and Drosophila nicotinic receptors.
AID375116Binding affinity to Aplysia californica AchBP A107M mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID246901Effective dose to induce antinociception in mouse determined in tail-flick test2005Journal of medicinal chemistry, Feb-24, Volume: 48, Issue:4
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
AID91525Ability to stimulate Rb+ efflux from human IMR-32 cell preparations containing human alpha3-betaX receptors1996Journal of medicinal chemistry, Feb-16, Volume: 39, Issue:4
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
AID91534Maximum efficacy relative to 100(uM) (S)-nicotine for cell preparations containing alpha3-betaX IMR32 cells1996Journal of medicinal chemistry, Feb-16, Volume: 39, Issue:4
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
AID1682129Potency index, ratio of morphine ED50 to test compound ED50 for antinociceptive activity in naloxone treated mouse assessed as induction of Straub-tail response2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID417950Displacement of [3H]cytisine from alpha4beta2 nAChR in rat brain membrane2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
AID147083Binding affinity at homopentameric Nicotinic acetylcholine receptor alpha-7 subtype using [3H]S-(-)-nicotine as radioligand1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Molecular recognition in nicotinic acetylcholine receptors: the importance of pi-cation interactions.
AID341261Displacement of [3H]epibatidine from rat alpha3beta2 nAChR expressed in HEK293 cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID417952Agonist activity at human recombinant alpha4beta2 nAChR expressed in human IMR32 cells assessed as calcium dynamics by FLIPR assay relative to nicotine2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
AID238148Dissociation constant against Nicotinic acetylcholine receptor alpha3-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID302772Displacement of [3H]cytisine from neuronal nicotinic acetylcholine receptor in rat brain membrane2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
AID146943Inhibition of [125I]- iodo-MLA binding at the Nicotinic acetylcholine receptor alpha-7 (nAChR) in male rat cerebral cortex2002Journal of medicinal chemistry, Oct-10, Volume: 45, Issue:21
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
AID282346Agonist activity at alpha-3-beta-4 nAChR in KXalpha-3-beta-4R2 cells by rubidium efflux assay relative to nicotine2004Journal of medicinal chemistry, Dec-30, Volume: 47, Issue:27
Coaxing a pyridine nucleus to give up its aromaticity: synthesis and pharmacological characterization of novel conformationally restricted analogues of nicotine and anabasine.
AID374883Binding affinity to Aplysia californica AchBP I118M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146155Agonistic activity against rat Alpha3 beta-4 Nicotinic Receptor expressed in Xenopus oocytes2001Journal of medicinal chemistry, Jan-04, Volume: 44, Issue:1
exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.
AID640180Displacement of [3H]bungarotoxin from nAChR alpha7 receptor on rat cortical membrane homogenate by gamma-counting2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Synthesis and binding affinity at α4β2 and α7 nicotinic acetylcholine receptors of new analogs of epibatidine and epiboxidine containing the 7-azabicyclo[2.2.1]hept-2-ene ring system.
AID374887Binding affinity to Aplysia californica AchBP Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146158Functional potency measured as stimulation at rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in Xenopus oocytes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID239589Displacement of [3H]-cytisine from Alpha4-beta2 Nicotinic acetylcholine receptor of rat brain homogenates2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.
AID1101296Toxicity against Musca domestica (house fly) dosed with compound through intra-thoracic injection pre-treated with 100 ug/g metabolic detoxification inhibitor O-propyl O-(2-propynyl)phenylphosphonate2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID1410540Displacement of [3H]epibatidine from rat forebrain nAChR after 4 hrs by liquid scintillation counting method2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID322339Antinociceptive activity in sc dosed in acute pain mouse model by hot plate method2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.
AID146939Binding potency for Nicotinic acetylcholine receptor alpha-7 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID291934Agonist activity at alpha-4-beta-2 in IMR-32cells assessed as calcium influx by FLIPR assay2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
AID244249Selectivity against Nicotinic acetylcholine receptor subtypes alpha3-beta4 and alpha4-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID302776Agonist activity at recombinant human alpha3beta4 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay relative to nicotine2007Journal of medicinal chemistry, Nov-01, Volume: 50, Issue:22
Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.
AID145853Inhibition of [3H]- epibatidine binding at the Nicotinic acetylcholine receptor alpha beta (nAChR) in male rat cerebral cortex2002Journal of medicinal chemistry, Oct-10, Volume: 45, Issue:21
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
AID1092037Binding affinity to Drosophila brain nicotinic acetylcholine receptor assessed as [3H]IMI binding by radioligand binding assay2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Unique neonicotinoid binding conformations conferring selective receptor interactions.
AID374846Binding affinity to Aplysia californica AchBP V108M mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146161Binding affinity towards Nicotinic acetylcholine receptor alpha3-beta4 using [3H]epibatidine2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
AID1101297Toxicity in ip dosed Mus musculus (mouse)2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID341259Displacement of [3H]epibatidine from rat alpha2beta2 nAChR expressed in HEK293 cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID1074614Displacement of [3H]-epibatidine from alpha4beta2* nAChR in Sprague-Dawley rat cerebral cortex after 4 hrs by liquid scintillation counting analysis2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID146483Binding affinity to Nicotinic acetylcholine receptor alpha4-beta2 using +/-[3H]epibatidine as radioligand in rat brain2002Journal of medicinal chemistry, Feb-28, Volume: 45, Issue:5
Synthesis and nicotinic binding studies on enantiopure diazine analogues of the novel (2-chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165.
AID465076Agonist activity at rat alpha3beta4 nAChR expressed in HEK cells assessed as membrane depolarization after 1 hr by HPLC based fluorescence assay2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.
AID145677Kapp value towards nicotinic acetylcholine receptor was obtained from three to four independent competition binding experiments using [3H]-NCEPB1997Journal of medicinal chemistry, Jul-18, Volume: 40, Issue:15
Synthesis and nicotinic acetylcholine receptor binding properties of exo-2-(2'-fluoro-5'-pyridinyl)-7-azabicyclo-[2.2.1]heptane: a new positron emission tomography ligand for nicotinic receptors.
AID132750In vivo analgesic agonist activity after subcutaneous administration, using hotplate assay2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
AID146007Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in Xenopus oocytes using [3H]epibatidine as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID397989Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
AID251184Percentage efficacy in TE671 cells expressing acetylcholine neuromuscular receptor as change in membrane potential2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID452526Inhibition of alpha3beta4 nAChR2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.
AID246397Change in membrane potential in TE-671 cells expressing acetylcholine neuromuscular receptors2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID146006Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.
AID146151Tested for binding affinity against Nicotinic acetylcholine receptor alpha3-beta42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID291935Agonist activity at rat striatal tissue assessed as dopamine release2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
AID238080Dissociation constant for nicotinic acetylcholine receptor alpha4-beta2 of mouse M10 cells; n=32005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
AID146470Binding affinity towards alpha4-beta2 nicotinic receptor was determined in rat brain membrane using [3H]cytisine as radioligand2003Bioorganic & medicinal chemistry letters, Mar-24, Volume: 13, Issue:6
Syntheses and biological properties of cysteine-reactive epibatidine derivatives.
AID374866Binding affinity to Aplysia californica AchBP M116Y, Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID1092036Binding affinity to recombinant Gallus gallus (chicken) alpha4beta2 nicotinic acetylcholine receptor assessed as [3H]NIC binding by radioligand binding assay2011Journal of agricultural and food chemistry, Apr-13, Volume: 59, Issue:7
Unique neonicotinoid binding conformations conferring selective receptor interactions.
AID145678Ability of compound to compete with 50 pM of 5-[125I]iodo-A-85,380 for receptor binding sites in rat brain membranes at room temperature2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential pr
AID375114Binding affinity to Aplysia californica AchBP I106M, M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID341263Displacement of [3H]epibatidine from rat alpha4beta4 nAChR expressed in HEK293 cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID465079Agonist activity at rat alpha3beta4 nAChR expressed in HEK cells assessed as elevation of intracellular calcium after 1 hr by HPLC based fluorescence assay2010Journal of natural products, Mar-26, Volume: 73, Issue:3
Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.
AID3056In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.
AID145686Compound was evaluated for its ability to displace [3H]-cytisine binding from high-affinity Nicotinic acetylcholine receptor in rat brain (principally the alpha4-beta2 nAChR subtype)1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
AID1410541Potency index, ratio of epibatidine Ki to racemic phantasmidine Ki for displacement of [3H]epibatidine from rat forebrain nAChR2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID1682126Antinociceptive activity in mouse2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID233593Ratio of IC50 values for displacing [3H]-MCC to [3H]OXO-M1999Journal of medicinal chemistry, Dec-02, Volume: 42, Issue:24
Improving the nicotinic pharmacophore with a series of (Isoxazole)methylene-1-azacyclic compounds: synthesis, structure-activity relationship, and molecular modeling.
AID177746Agonist activity against alpha beta Nicotinic acetylcholine receptor (nAChR) in male rat cerebral cortex in antinociceptive assay in hypothermia test2002Journal of medicinal chemistry, Oct-10, Volume: 45, Issue:21
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2',3'-disubstituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes: epibatidine analogues.
AID146931Binding affinity at rat brain Nicotinic acetylcholine receptor alpha72002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
AID374842Binding affinity to Aplysia californica AchBP A107M, M116L mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID452525Inhibition of alpha4beta2 nAChR2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.
AID146477Functional potency measured as stimulation at rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID146612In vitro binding affinity by inhibiting [3H]cytisine binding in rat brain tissue at Nicotinic acetylcholine receptor alpha4-beta22002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
AID146005Binding affinity towards Nicotinic acetylcholine receptor alpha3-beta2 using [3H]epibatidine2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
AID374877Binding affinity to Aplysia californica AchBP V108M mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID239419Binding affinity for nicotinic acetylcholine receptor alpha4-beta2 from mouse M10 cells; n=32005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
6'-Methylpyrido[3,4-b]norhomotropane: synthesis and outstanding potency in relation to the alpha4beta2 nicotinic receptor pharmacophore model.
AID115288Minimal dose able to induce a statistically significant increase of the pain threshold, done on mouse; sc1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID689290Displacement of [3H]epibatidine from chimeric human alpha7-5-HT3A receptor expressed in HEK293 cells after 2 hrs by scintillation counter analysis2012Bioorganic & medicinal chemistry, Oct-01, Volume: 20, Issue:19
Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain.
AID1074598Effect on hypothermia in sc dosed mouse after 30 mins2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID145846Binding affinity against nicotinic acetylcholine receptor using [3H]epibatidine as radioligand in rat brain tissue2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Synthesis and nicotinic receptor activity of a hydroxylated tropane.
AID1359523Displacement of [125I]alpha-bungarotoxin from alpha7 nAChR in rat hippocampal membranes2018European journal of medicinal chemistry, May-25, Volume: 152Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: Novel selective ligands with subnanomolar affinity for α
AID427649Displacement of [3H]epibatidine from rat alpha2beta4 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID1074608Antagonist activity at rat alpha7 nAChR expressed in Xenopus laevis oocytes assessed as inhibition of acetylcholine-induced current at 100 uM by two-electrode voltage clamp electrophysiological analysis relative to acetylcholine2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID146478In vitro binding affinity by inhibiting [3H]dopamine release in rat brain tissue at Nicotinic acetylcholine receptor alpha4-beta22002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
AID129321Antinociceptive activity was tested in the mouse tail-flick test at 15 mg/kg2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID322332Displacement of [125I]iodoMLA from alpha-7 nAChR in rat cerebral cortex2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.
AID146773Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in Xenopus oocytes using [3H]epibatidine as radioligand2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID145987Tested for binding affinity against Nicotinic acetylcholine receptor alpha2-beta42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID536867Agonist activity at rat alpha3beta4 nAChR expressed in HEK292 cells assessed as increase of calcium influx by FLIPR assay2010Journal of medicinal chemistry, Nov-25, Volume: 53, Issue:22
Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
AID146458Binding potency for Nicotinic acetylcholine receptor alpha4-beta2 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID146774Functional potency measured as maximum stimulation at rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in Xenopus oocytes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID21871Calculated partition coefficient (clogP)2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential pr
AID239452Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha4-beta2 in rat cerebral cortex2005Journal of medicinal chemistry, Feb-24, Volume: 48, Issue:4
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
AID371856Binding affinity to Aplysia californica AchBP M116L mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID246869Effective dose to induce spontaneous activity in mouse was determined2005Journal of medicinal chemistry, Feb-24, Volume: 48, Issue:4
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-substituted deschloroepibatidine analogues. Novel nicotinic antagonists.
AID417953Agonist activity at human recombinant alpha3beta4 nAChR expressed in human IMR32 cells assessed as calcium dynamics by FLIPR assay2009Bioorganic & medicinal chemistry letters, Mar-15, Volume: 19, Issue:6
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
AID195570Agonistic activity against Rat muscle Nicotinic Receptor2001Journal of medicinal chemistry, Jan-04, Volume: 44, Issue:1
exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.
AID1074600Antinociceptive activity in sc dosed mouse after 5 mins by tail flick test2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID21870Calculated partition coefficient (clogD7.4)2004Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential pr
AID374864Binding affinity to Aplysia californica AchBP M116Y mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146768Tested for binding affinity against Nicotinic acetylcholine receptor alpha4-beta42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID1410545Agonist activity at human alpha4beta2 nAChR by cell-based rubidium flux assay relative to 100 uM nicotine2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID254463In vitro binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 using 0.5 nM [3H]epibatidine2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID129319Antinociceptive activity was tested in the mouse hot plate test at 15 mg/kg2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID310061Inhibition of alpha-4-beta-2 nAChR2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
Unique spirocyclopiperazinium salt III: further investigation of monospirocyclopiperazinium (MSPZ) salts as potential analgesics.
AID145821In vitro inhibition of 5-(125I)A-85380 binding to nicotinic acetylcholine receptor (nAChR) of rat brain2002Journal of medicinal chemistry, Jun-20, Volume: 45, Issue:13
Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors.
AID256414Agonistic activity as [86Rb+] efflux from KXalpha-3-beta-4R2 cells expressing rat Nicotinic acetylcholine receptor at 100 uM2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID1101293Inhibition of [3H]alpha-BGT binding to alpha7 nicotinic acetylcholine receptor in Homo sapiens (human) SH-SY5Y cells2000Journal of agricultural and food chemistry, Dec, Volume: 48, Issue:12
Neonicotinoid insecticides: molecular features conferring selectivity for insect versus mammalian nicotinic receptors.
AID1410539Potency index, ratio of epibatidine Ki to racemic phantasmidine Ki for displacement of [3H]epibatidine from alpha4beta2 nAChR (unknown origin) expressed in HEK cell membranes2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID374836Binding affinity to Aplysia californica AchBP I106M, M116L mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146769Tested for binding affinity against Nicotinic acetylcholine receptor alpha4-beta42003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID251066Percentage efficacy in KXalpha-3-beta-4R2 cells expressing rat nicotinic acetylcholine receptor alpha3 beta-4 subunits relative to (1)-epibatidine2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID146637Binding affinity against nicotinic acetylcholine receptor alpha4-beta2 using [3H]epibatidine as radioligand expressed in HEK293 cells or tsA cells2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
Synthesis and nicotinic receptor activity of a hydroxylated tropane.
AID91526Cholinergic interactions was measured with FLIPR device on IMR-32 cells of human neuroblastoma clonal line, given as effective dose1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID375123Binding affinity to Aplysia californica AchBP S114M, M116L, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID238149Dissociation constant against Nicotinic acetylcholine receptor alpha3-beta42005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID1074599Antinociceptive activity in sc dosed mouse by hot plate test2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID536863Displacement of [3H]epibatidine from rat alpha4beta2 nAChR expressed in HEK292 cells after 3 hrs2010Journal of medicinal chemistry, Nov-25, Volume: 53, Issue:22
Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
AID488648Displacement of [125I]alpha-Bungarotoxin from alpha7 nAChR in rat cortical membrane2010Bioorganic & medicinal chemistry, Jun-15, Volume: 18, Issue:12
Novel tricyclic Delta(2)-isoxazoline and 3-oxo-2-methyl-isoxazolidine derivatives: synthesis and binding affinity at neuronal nicotinic acetylcholine receptor subtypes.
AID238150Dissociation constant against Nicotinic acetylcholine receptor alpha4-beta22005Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6
Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.
AID322331Displacement of [3H]epibatidine from alpha-4-beta-2 nAChR in rat cerebral cortex2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.
AID145859Tested for binding affinity against Nicotinic acetylcholine receptor alpha2-beta22003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID1682119Binding affinity to human alpha3beta4 nAChR2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID219638Functional potency for nAChR subtype Alpha-1-beta-1-delta gamma (torpedo)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID322358Effect on locomotor activity in sc dosed mouse assessed as spontaneous activity2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.
AID146464Agonistic activity against rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in Xenopus oocytes2001Journal of medicinal chemistry, Jan-04, Volume: 44, Issue:1
exo-2-(Pyridazin-4-yl)-7-azabicyclo[2.2.1]heptanes: syntheses and nicotinic acetylcholine receptor agonist activity of potent pyridazine analogues of (+/-)-epibatidine.
AID146455Binding affinity at rat brain Nicotinic acetylcholine receptor alpha4-beta22002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
AID242894Maximal response against Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
AID375127Binding affinity to Aplysia californica AchBP M116Y, Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID132953Compound was evaluated for the analgesic activity by mouse hotplate assay at the dose 0.1; No significant effect observed at the doses tested1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
AID254464In vitro binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 using 0.5 nM [3H]epibatidine2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID409996Displacement of [3H]epibatine from nAChR in rat cortical membrane2008Bioorganic & medicinal chemistry letters, Dec-01, Volume: 18, Issue:23
New synthesis and evaluation of enantiomers of 7-methyl-2-exo-(3'-iodo-5'-pyridinyl)-7-azabicyclo[2.2.1]heptane as stereoselective ligands for PET imaging of nicotinic acetylcholine receptors.
AID146000Tested for binding affinity against Nicotinic acetylcholine receptor alpha3-beta22003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID291933Displacement of [3H]cytisine from alpha-4-beta-2 in rat cerebral cortical membrane2007Journal of medicinal chemistry, Jul-26, Volume: 50, Issue:15
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptors.
AID1682123Potency index, ratio of nicotine IC50 to test compound IC50 for displacement of [3H]cytisine from rat brain nAChR using radiolabelled compound2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID375113Binding affinity to Aplysia californica AchBP M116L,Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID374852Binding affinity to Aplysia californica AchBP S114M mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID129320Antinociceptive activity was tested in the mouse tail-flick test2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID145981Binding affinity towards nicotinic acetylcholine receptor alpha2-beta2 using [3H]epibatidine2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.
AID397991Selectivity ratio of Ki for alpha7 nicotinic acetylcholine receptor to Ki for alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
Octahydropyrrolo[3,4-c]pyrrole: a diamine scaffold for construction of either alpha4beta2 or alpha7-selective nicotinic acetylcholine receptor (nAChR) ligands. Substitutions that switch subtype selectivity.
AID322334Antinociceptive activity in sc dosed acute pain mouse model by tail flick method2008Bioorganic & medicinal chemistry, Jan-15, Volume: 16, Issue:2
Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3'-(substituted phenyl)deschloroepibatidine analogs.
AID132751In vivo analgesic agonist activity after subcutaneous administration, using tail-flick assay2002Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
Synthesis and biological evaluation at nicotinic acetylcholine receptors of N-arylalkyl- and N-aryl-7-azabicyclo[2.2.1]heptanes.
AID243385Binding affinity (Ki) for rat nicotinic acetylcholine receptor alpha3-beta4 subunits versus 0.5 nM [3H](1)-epibatidine2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID146159Binding affinity at rat brain Nicotinic acetylcholine receptor alpha3-beta42002Journal of medicinal chemistry, Jul-18, Volume: 45, Issue:15
Synthesis and pharmacological characterization of novel analogues of the nicotinic acetylcholine receptor agonist (+/-)-UB-165.
AID146462Tested for binding affinity against Nicotinic acetylcholine receptor alpha4-beta22003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID374832Binding affinity to Aplysia californica AchBP Y195F mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID145845Agonist activity against Nicotinic acetylcholine receptor (nAchR)1999Journal of medicinal chemistry, May-06, Volume: 42, Issue:9
Emerging molecular approaches to pain therapy.
AID341258Displacement of [3H]epibatidine from rat alpha4beta2 nAChR expressed in HEK293 cells2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging propert
AID254461In vitro binding affinity towards rat Nicotinic acetylcholine receptor alpha2-beta2 using 0.5 nM [3H]epibatidine2005Bioorganic & medicinal chemistry letters, Oct-01, Volume: 15, Issue:19
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.
AID264239Displacement of [3H]epibatidine from rat alpha-4-beta-4 nACHR expressed in human HEK293 cells2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.
AID242892Maximal response against Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells2005Journal of medicinal chemistry, Jul-28, Volume: 48, Issue:15
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
AID452524Displacement of [3H]585539 from alpha7 nAChR in rat brain2010Bioorganic & medicinal chemistry letters, Jan-01, Volume: 20, Issue:1
Structure-activity relationships of N-substituted ligands for the alpha7 nicotinic acetylcholine receptor.
AID1682334Displacement of [125I]alpha-bungarotoxin from human alpha7 nAChR expressed in K28 cell membrane2020Bioorganic & medicinal chemistry, 12-15, Volume: 28, Issue:24
Pyridine alkaloids with activity in the central nervous system.
AID116105Maximal nontoxic dose of the compound, done on mouse; sc1998Journal of medicinal chemistry, Feb-26, Volume: 41, Issue:5
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling.
AID243384Binding affinity (Ki) for rat brain nicotinic receptors ganglionic-type alpha-4 and beta2 subunits versus 0.5 nM [3H](1)-epibatidine2005Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4
Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.
AID175480Compound was evaluated for functional potencies and efficacies at rat nAChR subtype DA release1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID146798Functional potency for Nicotinic acetylcholine receptor alpha-7 (rat brain)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID374871Binding affinity to Aplysia californica AchBP M116L,Y195F mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID427654Displacement of [3H]epibatidine from rat alpha4beta4 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting2009Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13
Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.
AID1410559Toxicity in iv dosed Swiss-Webster mouse2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID1074597Effect on spontaneous activity in sc dosed mouse after 5 mins2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID1410543Agonist activity at rat alpha3beta4 nAChR by cell-based rubidium flux assay relative to 100 uM nicotine2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID1410546Selectivity ratio of EC50 for agonist activity at rat alpha3beta4 nAChR (unknown origin) to EC50 for agonist activity at alpha4beta2 nAChR (unknown origin)2018Journal of natural products, 04-27, Volume: 81, Issue:4
Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.
AID146164Functional potency measured as maximum stimulation at rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in Xenopus oocytes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1074610Antagonist activity at rat alpha4beta2 nAChR expressed in Xenopus laevis oocytes assessed as inhibition of acetylcholine-induced current at 100 uM by two-electrode voltage clamp electrophysiological analysis relative to acetylcholine2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
AID374886Binding affinity to Aplysia californica AchBP M116L mutant expressed in HEK293S cells assessed as specific photoincorporation at 46 pmol by scintillation counting relative to wild type2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID146620Inhibition of [3H]nicotine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID145356Compound was evaluated for functional potencies and efficacies at human Nicotinic acetylcholine receptor subtype IMR-32 (ganglionic)1997Journal of medicinal chemistry, Dec-19, Volume: 40, Issue:26
Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
AID146452Tested for binding affinity against Nicotinic acetylcholine receptor alpha4-beta22003Journal of medicinal chemistry, Mar-13, Volume: 46, Issue:6
Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.
AID374840Binding affinity to Aplysia californica AchBP A107M mutant expressed in HEK293S cells by scintillation proximity assay2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Nicotinic agonist binding site mapped by methionine- and tyrosine-scanning coupled with azidochloropyridinyl photoaffinity labeling.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1799850Interaction Assay from Article 10.1021/bi1006354: \\Interaction kinetic and structural dynamic analysis of ligand binding to acetylcholine-binding protein.\\2010Biochemistry, Sep-21, Volume: 49, Issue:37
Interaction kinetic and structural dynamic analysis of ligand binding to acetylcholine-binding protein.
AID1799761Radioligand Competition Assay from Article 10.1074/jbc.M111.292243: \\Intersubunit bridge formation governs agonist efficacy at nicotinic acetylcholine u00CEu00B14u00CEu00B22 receptors: unique role of halogen bonding revealed.\\2012The Journal of biological chemistry, Feb-03, Volume: 287, Issue:6
Intersubunit bridge formation governs agonist efficacy at nicotinic acetylcholine α4β2 receptors: unique role of halogen bonding revealed.
AID239319Inhibition of alpha beta[3H]epibatidine binding to Nicotinic acetylcholine receptor alpha4-beta2 of rat cerebral cortex2004Journal of medicinal chemistry, Aug-26, Volume: 47, Issue:18
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.
AID265650Hypothermia in mouse2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
AID129323Antinociceptive activity was tested in the mouse tail-flick test from ref 172004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1275134Binding affinity to alpha4beta2 nACh receptor (unknown origin) expressed in Xenopus oocytes2016European journal of medicinal chemistry, Jan-27, Volume: 108Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
AID246832Antinociceptive response was determined in mice using hypothermia method2004Journal of medicinal chemistry, Aug-26, Volume: 47, Issue:18
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.
AID1275131Selectivity ratio of Ki for rat alpha4beta2 nACh receptor to Ki for human alpha3beta4 nACh receptor2016European journal of medicinal chemistry, Jan-27, Volume: 108Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
AID1563867Displacement of [3H]epibatidine from human alpha3beta4 nAChR transfected in HEK243 cell membrane
AID265653Spontaneous activity in mouse2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
AID1739243Displacement of [125I] alpha bungarotoxin from human neuronal alpha7 nAChR expressed in human SH-SY5Y cell membrane measured after 120 mins by Topcount scintillation counting method2020European journal of medicinal chemistry, Aug-15, Volume: 200Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
AID1275129Displacement of [125I] alpha bungarotoxin from rat alpha7 nACh receptor expressed in rat hippocampal membrane preincubated for 30 mins followed by radioligand addition by gamma counting analysis2016European journal of medicinal chemistry, Jan-27, Volume: 108Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
AID129322Antinociceptive activity was tested in the mouse tail-flick test from ref 152004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1275132Selectivity ratio of Ki for rat alpha7 nACh receptor to Ki for human alpha3beta4 nACh receptor2016European journal of medicinal chemistry, Jan-27, Volume: 108Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
AID265642Antinociceptive activity in mouse by tail flick assay2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
AID129320Antinociceptive activity was tested in the mouse tail-flick test2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1563865Displacement of [125I]alpha-bungarotoxin from alpha7nAChR in rat hippocampus membrane
AID1102410Displacement of [3HIMI from nicotinic acetylcholine receptor in Musca domestica (house fly) head membranes incubated for 60 min by liquid scintillation counting method2003Bioscience, biotechnology, and biochemistry, May, Volume: 67, Issue:5
Asymmetric chloronicotinyl insecticide, 1-[1-(6-chloro-3-pyridyl)ethyl]-2-nitroiminoimidazolidine: preparation, resolution and biological activities toward insects and their nerve preparations.
AID225733Inhibition of [3H]nicotine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes from ref 152004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID35535Inhibition of [3H]epibatidine binding at the alpha beta nicotinic AChR in male rat cerebral cortex2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted-3'-phenyl-5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Novel nicotinic antagonist.
AID276254Displacement of [3H]Nicotine from alpha4beta2 nAChR in rat cortical membranes2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Epibatidine isomers and analogues: structure-activity relationships.
AID1739245Displacement of [125I] alpha bungarotoxin from human neuronal alpha4beta2 nAChR expressed in human SH-SY5Y cell membrane measured after 120 mins by Topcount scintillation counting method2020European journal of medicinal chemistry, Aug-15, Volume: 200Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
AID276256Selectivity for rat alpha4beta2 nAChR over rat alpha-7 nAChR2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Epibatidine isomers and analogues: structure-activity relationships.
AID265641Displacement of [3H]epibatidine from alpha-4-beta-2 nACHR in rat cerebral cortex2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
AID146621Inhibition of [3H]nicotine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes from ref 142004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID146620Inhibition of [3H]nicotine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID265646Antinociceptive activity in sc dosed mouse by hot plate assay after 5 mins2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
AID129297Antinociception by tail-flick test in male ICR mice after intrathecal (i.t.) injection2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
AID276255Displacement of [125I-alpha]-Bungarotoxin from alpha-7 nAChR in rat hippocampal membranes2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Epibatidine isomers and analogues: structure-activity relationships.
AID1739244Displacement of [125I] alpha bungarotoxin from human muscle type nAChR expressed in human TE-671 cell membrane measured after 120 mins by Topcount scintillation counting method2020European journal of medicinal chemistry, Aug-15, Volume: 200Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
AID146476Non-specific binding in presence of 300 uM nicotine at nicotinic acetylcholine receptor alpha4-beta2 in rat cerebral cortex membranes2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
AID239201Inhibition of [125I]-iodo-MLA binding to Nicotinic acetylcholine receptor alpha-7 of rat cerebral cortex2004Journal of medicinal chemistry, Aug-26, Volume: 47, Issue:18
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.
AID131354Drug discrimination in mice from ref 152004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1275130Displacement of [125I] alpha bungarotoxin from human alpha7 nACh receptor incubated for 20 secs2016European journal of medicinal chemistry, Jan-27, Volume: 108Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
AID131576Spontaneous activity in mice from ref 152004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID129318Antinociceptive activity was tested in the mouse hot plate test2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID1275133Binding affinity to alpha3beta4 nACh receptor (unknown origin) expressed in Xenopus oocytes2016European journal of medicinal chemistry, Jan-27, Volume: 108Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype.
AID1563864Displacement of [3H]epibatidine from alpha4beta2 nAChR in rat cerebral cortex membrane
AID146473Inhibition of [3H]epibatidine binding at the nicotinic acetylcholine receptor alpha4-beta2 in male rat cerebral cortex2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
AID246831Antinociceptive response was determined in mice using tail flick method2004Journal of medicinal chemistry, Aug-26, Volume: 47, Issue:18
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.
AID146618Inhibition of [3H]epibatidine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes from ref 162004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID146941Inhibition of [125I]MLA binding to Nicotinic acetylcholine receptor alpha7 from rat brain membranes2004Bioorganic & medicinal chemistry letters, Apr-19, Volume: 14, Issue:8
Epibatidine structure-activity relationships.
AID226647Hill slope value of the compound2001Journal of medicinal chemistry, Jun-21, Volume: 44, Issue:13
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2-exo-2-(2'-substituted 5'-pyridinyl)-7-azabicyclo[2.2.1]heptanes. Epibatidine analogues.
AID246838Antinociceptive response was determined in mice using hot plate flick method2004Journal of medicinal chemistry, Aug-26, Volume: 47, Issue:18
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted phenyl)deschloroepibatidine analogues. Novel nicotinic antagonist.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (637)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's124 (19.47)18.2507
2000's363 (56.99)29.6817
2010's141 (22.14)24.3611
2020's9 (1.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.04 (24.57)
Research Supply Index4.26 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index66.73 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews22 (3.71%)6.00%
Reviews5 (7.14%)6.00%
Reviews1 (8.33%)6.00%
Case Studies2 (0.34%)4.05%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other569 (95.95%)84.16%
Other65 (92.86%)84.16%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]